BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18029597)

  • 41. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.
    Ganem NS; Ben-Asher N; Lamm AT
    Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An efficient system for selectively altering genetic information within mRNAs.
    Montiel-González MF; Vallecillo-Viejo IC; Rosenthal JJ
    Nucleic Acids Res; 2016 Dec; 44(21):e157. PubMed ID: 27557710
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ADAR-mediated RNA editing in non-coding RNA sequences.
    Yang Y; Zhou X; Jin Y
    Sci China Life Sci; 2013 Oct; 56(10):944-52. PubMed ID: 24008387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of new targets of Drosophila pre-mRNA adenosine deaminase.
    Xia S; Yang J; Su Y; Qian J; Ma E; Haddad GG
    Physiol Genomics; 2005 Jan; 20(2):195-202. PubMed ID: 15522950
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A method for finding sites of selective adenosine deamination.
    Ohlson J; Ohman M
    Methods Enzymol; 2007; 424():289-300. PubMed ID: 17662846
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of binding domains for dsRNA and Z-DNA in the in vivo editing of minimal substrates by ADAR1.
    Herbert A; Rich A
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12132-7. PubMed ID: 11593027
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of substrates for adenosine deaminases that act on RNA.
    Morse DP
    Methods Mol Biol; 2004; 265():199-218. PubMed ID: 15103075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Altered editing in RNA editing adenosine deaminase ADAR2 gene transcripts of systemic lupus erythematosus T lymphocytes.
    Laxminarayana D; O'Rourke KS; Maas S; Olorenshaw I
    Immunology; 2007 Jul; 121(3):359-69. PubMed ID: 17376196
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimal guideRNAs for re-directing deaminase activity of hADAR1 and hADAR2 in trans.
    Schneider MF; Wettengel J; Hoffmann PC; Stafforst T
    Nucleic Acids Res; 2014 Jun; 42(10):e87. PubMed ID: 24744243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective inhibition of ADAR2-catalyzed editing of the serotonin 2c receptor pre-mRNA by a helix-threading peptide.
    Schirle NT; Goodman RA; Krishnamurthy M; Beal PA
    Org Biomol Chem; 2010 Nov; 8(21):4898-904. PubMed ID: 20820662
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A-to-I RNA editing - thinking beyond the single nucleotide.
    Ganem NS; Lamm AT
    RNA Biol; 2017 Dec; 14(12):1690-1694. PubMed ID: 28820319
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A-to-I editing of protein coding and noncoding RNAs.
    Mallela A; Nishikura K
    Crit Rev Biochem Mol Biol; 2012; 47(6):493-501. PubMed ID: 22988838
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of exceptionally potent adenosine deaminases RNA editors from high body temperature organisms.
    Avram-Shperling A; Kopel E; Twersky I; Gabay O; Ben-David A; Karako-Lampert S; Rosenthal JJC; Levanon EY; Eisenberg E; Ben-Aroya S
    PLoS Genet; 2023 Mar; 19(3):e1010661. PubMed ID: 36877730
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functions and regulation of RNA editing by ADAR deaminases.
    Nishikura K
    Annu Rev Biochem; 2010; 79():321-49. PubMed ID: 20192758
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The dynamic epitranscriptome: A to I editing modulates genetic information.
    Tajaddod M; Jantsch MF; Licht K
    Chromosoma; 2016 Mar; 125(1):51-63. PubMed ID: 26148686
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [RNA editing in eukaryotic genome expression].
    Pankratova EV; Stepchenko AG
    Genetika; 2010 Jan; 46(1):5-13. PubMed ID: 20198873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [ADAR-mediated messenger RNA editing: analysis at the proteome level].
    Kliuchnikova AA; Kuznetsova KG; Moshkovskii SA
    Biomed Khim; 2016 Jul; 62(5):510-519. PubMed ID: 27797325
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modulation of microRNA expression and function by ADARs.
    Wulff BE; Nishikura K
    Curr Top Microbiol Immunol; 2012; 353():91-109. PubMed ID: 21761289
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic code restoration by artificial RNA editing of Ochre stop codon with ADAR1 deaminase.
    Bhakta S; Azad MTA; Tsukahara T
    Protein Eng Des Sel; 2018 Dec; 31(12):471-478. PubMed ID: 31120126
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro and in cellula site-directed RNA editing using the λNDD-BoxB system.
    Ojha N; Diaz Quiroz JF; Rosenthal JJC
    Methods Enzymol; 2021; 658():335-358. PubMed ID: 34517953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.